Targeting the appropriate medications to the appropriate patients at the appropriate times is the aim of precision medicine. Precision medicine has already produced significant new findings and FDA-approved therapies that are tailored to a person鈥檚 unique traits, such as their genetic makeup or the genetic profile of their tumor. Molecular testing is frequently administered to patients with different types of cancer as part of patient care, allowing medical professionals to choose therapies that raise survival rates and lower the risk of side effects.
The global Artificial Intelligence (AI) in Precision Medicine market was valued at US$ 2273 million in 2022 and is anticipated to reach US$ 6095.6 million by 2029, witnessing a CAGR of 17.9% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Artificial Intelligence (AI) in Precision Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Artificial Intelligence (AI) in Precision Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Artificial Intelligence (AI) in Precision Medicine in Oncology is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Artificial Intelligence (AI) in Precision Medicine include Atomwise Inc, Alphabet Inc., AstraZeneca, BioXcel Therapeutics Inc., Berg LLC, Enlitic Inc., GE Healthcare, Insilico Medicine and Intel Corporation, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence (AI) in Precision Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence (AI) in Precision Medicine.
The Artificial Intelligence (AI) in Precision Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Artificial Intelligence (AI) in Precision Medicine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence (AI) in Precision Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Atomwise Inc
Alphabet Inc.
AstraZeneca
BioXcel Therapeutics Inc.
Berg LLC
Enlitic Inc.
GE Healthcare
Insilico Medicine
Intel Corporation
IQVIA
IBM Corporation
Modernizing Medicine Inc.
NVIDIA Corporation
Microsoft Corporation
Novo Nordisk A/S
Sanofi
Sensely Inc.
Tempus
Zephyr AI
Segment by Type
Hardware
Software and Service
Segment by Application
Oncology
Neurology
Cardiology
Respiratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence (AI) in Precision Medicine companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence (AI) in Precision Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Hardware
1.2.3 Software and Service
1.3 Market by Application
1.3.1 Global Artificial Intelligence (AI) in Precision Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Neurology
1.3.4 Cardiology
1.3.5 Respiratory
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence (AI) in Precision Medicine Market Perspective (2018-2029)
2.2 Artificial Intelligence (AI) in Precision Medicine Growth Trends by Region
2.2.1 Global Artificial Intelligence (AI) in Precision Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Intelligence (AI) in Precision Medicine Historic Market Size by Region (2018-2023)
2.2.3 Artificial Intelligence (AI) in Precision Medicine Forecasted Market Size by Region (2024-2029)
2.3 Artificial Intelligence (AI) in Precision Medicine Market Dynamics
2.3.1 Artificial Intelligence (AI) in Precision Medicine Industry Trends
2.3.2 Artificial Intelligence (AI) in Precision Medicine Market Drivers
2.3.3 Artificial Intelligence (AI) in Precision Medicine Market Challenges
2.3.4 Artificial Intelligence (AI) in Precision Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence (AI) in Precision Medicine Players by Revenue
3.1.1 Global Top Artificial Intelligence (AI) in Precision Medicine Players by Revenue (2018-2023)
3.1.2 Global Artificial Intelligence (AI) in Precision Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Intelligence (AI) in Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence (AI) in Precision Medicine Revenue
3.4 Global Artificial Intelligence (AI) in Precision Medicine Market Concentration Ratio
3.4.1 Global Artificial Intelligence (AI) in Precision Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence (AI) in Precision Medicine Revenue in 2022
3.5 Artificial Intelligence (AI) in Precision Medicine Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence (AI) in Precision Medicine Product Solution and Service
3.7 Date of Enter into Artificial Intelligence (AI) in Precision Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence (AI) in Precision Medicine Breakdown Data by Type
4.1 Global Artificial Intelligence (AI) in Precision Medicine Historic Market Size by Type (2018-2023)
4.2 Global Artificial Intelligence (AI) in Precision Medicine Forecasted Market Size by Type (2024-2029)
5 Artificial Intelligence (AI) in Precision Medicine Breakdown Data by Application
5.1 Global Artificial Intelligence (AI) in Precision Medicine Historic Market Size by Application (2018-2023)
5.2 Global Artificial Intelligence (AI) in Precision Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Artificial Intelligence (AI) in Precision Medicine Market Size (2018-2029)
6.2 North America Artificial Intelligence (AI) in Precision Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Artificial Intelligence (AI) in Precision Medicine Market Size by Country (2018-2023)
6.4 North America Artificial Intelligence (AI) in Precision Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence (AI) in Precision Medicine Market Size (2018-2029)
7.2 Europe Artificial Intelligence (AI) in Precision Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Artificial Intelligence (AI) in Precision Medicine Market Size by Country (2018-2023)
7.4 Europe Artificial Intelligence (AI) in Precision Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence (AI) in Precision Medicine Market Size (2018-2029)
8.2 Asia-Pacific Artificial Intelligence (AI) in Precision Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Artificial Intelligence (AI) in Precision Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Artificial Intelligence (AI) in Precision Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence (AI) in Precision Medicine Market Size (2018-2029)
9.2 Latin America Artificial Intelligence (AI) in Precision Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Artificial Intelligence (AI) in Precision Medicine Market Size by Country (2018-2023)
9.4 Latin America Artificial Intelligence (AI) in Precision Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence (AI) in Precision Medicine Market Size (2018-2029)
10.2 Middle East & Africa Artificial Intelligence (AI) in Precision Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Artificial Intelligence (AI) in Precision Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Artificial Intelligence (AI) in Precision Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Atomwise Inc
11.1.1 Atomwise Inc Company Detail
11.1.2 Atomwise Inc Business Overview
11.1.3 Atomwise Inc Artificial Intelligence (AI) in Precision Medicine Introduction
11.1.4 Atomwise Inc Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.1.5 Atomwise Inc Recent Development
11.2 Alphabet Inc.
11.2.1 Alphabet Inc. Company Detail
11.2.2 Alphabet Inc. Business Overview
11.2.3 Alphabet Inc. Artificial Intelligence (AI) in Precision Medicine Introduction
11.2.4 Alphabet Inc. Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.2.5 Alphabet Inc. Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Artificial Intelligence (AI) in Precision Medicine Introduction
11.3.4 AstraZeneca Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.3.5 AstraZeneca Recent Development
11.4 BioXcel Therapeutics Inc.
11.4.1 BioXcel Therapeutics Inc. Company Detail
11.4.2 BioXcel Therapeutics Inc. Business Overview
11.4.3 BioXcel Therapeutics Inc. Artificial Intelligence (AI) in Precision Medicine Introduction
11.4.4 BioXcel Therapeutics Inc. Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.4.5 BioXcel Therapeutics Inc. Recent Development
11.5 Berg LLC
11.5.1 Berg LLC Company Detail
11.5.2 Berg LLC Business Overview
11.5.3 Berg LLC Artificial Intelligence (AI) in Precision Medicine Introduction
11.5.4 Berg LLC Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.5.5 Berg LLC Recent Development
11.6 Enlitic Inc.
11.6.1 Enlitic Inc. Company Detail
11.6.2 Enlitic Inc. Business Overview
11.6.3 Enlitic Inc. Artificial Intelligence (AI) in Precision Medicine Introduction
11.6.4 Enlitic Inc. Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.6.5 Enlitic Inc. Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Detail
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Artificial Intelligence (AI) in Precision Medicine Introduction
11.7.4 GE Healthcare Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.7.5 GE Healthcare Recent Development
11.8 Insilico Medicine
11.8.1 Insilico Medicine Company Detail
11.8.2 Insilico Medicine Business Overview
11.8.3 Insilico Medicine Artificial Intelligence (AI) in Precision Medicine Introduction
11.8.4 Insilico Medicine Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.8.5 Insilico Medicine Recent Development
11.9 Intel Corporation
11.9.1 Intel Corporation Company Detail
11.9.2 Intel Corporation Business Overview
11.9.3 Intel Corporation Artificial Intelligence (AI) in Precision Medicine Introduction
11.9.4 Intel Corporation Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.9.5 Intel Corporation Recent Development
11.10 IQVIA
11.10.1 IQVIA Company Detail
11.10.2 IQVIA Business Overview
11.10.3 IQVIA Artificial Intelligence (AI) in Precision Medicine Introduction
11.10.4 IQVIA Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.10.5 IQVIA Recent Development
11.11 IBM Corporation
11.11.1 IBM Corporation Company Detail
11.11.2 IBM Corporation Business Overview
11.11.3 IBM Corporation Artificial Intelligence (AI) in Precision Medicine Introduction
11.11.4 IBM Corporation Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.11.5 IBM Corporation Recent Development
11.12 Modernizing Medicine Inc.
11.12.1 Modernizing Medicine Inc. Company Detail
11.12.2 Modernizing Medicine Inc. Business Overview
11.12.3 Modernizing Medicine Inc. Artificial Intelligence (AI) in Precision Medicine Introduction
11.12.4 Modernizing Medicine Inc. Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.12.5 Modernizing Medicine Inc. Recent Development
11.13 NVIDIA Corporation
11.13.1 NVIDIA Corporation Company Detail
11.13.2 NVIDIA Corporation Business Overview
11.13.3 NVIDIA Corporation Artificial Intelligence (AI) in Precision Medicine Introduction
11.13.4 NVIDIA Corporation Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.13.5 NVIDIA Corporation Recent Development
11.14 Microsoft Corporation
11.14.1 Microsoft Corporation Company Detail
11.14.2 Microsoft Corporation Business Overview
11.14.3 Microsoft Corporation Artificial Intelligence (AI) in Precision Medicine Introduction
11.14.4 Microsoft Corporation Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.14.5 Microsoft Corporation Recent Development
11.15 Novo Nordisk A/S
11.15.1 Novo Nordisk A/S Company Detail
11.15.2 Novo Nordisk A/S Business Overview
11.15.3 Novo Nordisk A/S Artificial Intelligence (AI) in Precision Medicine Introduction
11.15.4 Novo Nordisk A/S Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.15.5 Novo Nordisk A/S Recent Development
11.16 Sanofi
11.16.1 Sanofi Company Detail
11.16.2 Sanofi Business Overview
11.16.3 Sanofi Artificial Intelligence (AI) in Precision Medicine Introduction
11.16.4 Sanofi Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.16.5 Sanofi Recent Development
11.17 Sensely Inc.
11.17.1 Sensely Inc. Company Detail
11.17.2 Sensely Inc. Business Overview
11.17.3 Sensely Inc. Artificial Intelligence (AI) in Precision Medicine Introduction
11.17.4 Sensely Inc. Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.17.5 Sensely Inc. Recent Development
11.18 Tempus
11.18.1 Tempus Company Detail
11.18.2 Tempus Business Overview
11.18.3 Tempus Artificial Intelligence (AI) in Precision Medicine Introduction
11.18.4 Tempus Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.18.5 Tempus Recent Development
11.19 Zephyr AI
11.19.1 Zephyr AI Company Detail
11.19.2 Zephyr AI Business Overview
11.19.3 Zephyr AI Artificial Intelligence (AI) in Precision Medicine Introduction
11.19.4 Zephyr AI Revenue in Artificial Intelligence (AI) in Precision Medicine Business (2018-2023)
11.19.5 Zephyr AI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Atomwise Inc
Alphabet Inc.
AstraZeneca
BioXcel Therapeutics Inc.
Berg LLC
Enlitic Inc.
GE Healthcare
Insilico Medicine
Intel Corporation
IQVIA
IBM Corporation
Modernizing Medicine Inc.
NVIDIA Corporation
Microsoft Corporation
Novo Nordisk A/S
Sanofi
Sensely Inc.
Tempus
Zephyr AI
听
听
*If Applicable.
